T. Rowe Price Associates’s Cassava Sciences SAVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65K | Buy |
35,868
+4,441
| +14% | +$8.05K | ﹤0.01% | 2966 |
|
|
2025
Q1 | $48K | Sell |
31,427
-4,939
| -14% | -$7.54K | ﹤0.01% | 2935 |
|
|
2024
Q4 | $86K | Buy |
36,366
+1,032
| +3% | +$2.44K | ﹤0.01% | 2854 |
|
|
2024
Q3 | $1.04M | Buy |
35,334
+550
| +2% | +$16.2K | ﹤0.01% | 1954 |
|
|
2024
Q2 | $430K | Buy |
34,784
+3,457
| +11% | +$42.7K | ﹤0.01% | 2248 |
|
|
2024
Q1 | $636K | Buy |
31,327
+1,456
| +5% | +$29.6K | ﹤0.01% | 2114 |
|
|
2023
Q4 | $673K | Buy |
29,871
+2,282
| +8% | +$51.4K | ﹤0.01% | 2044 |
|
|
2023
Q3 | $460K | Buy |
27,589
+870
| +3% | +$14.5K | ﹤0.01% | 2142 |
|
|
2023
Q2 | $656K | Sell |
26,719
-248
| -0.9% | -$6.09K | ﹤0.01% | 2005 |
|
|
2023
Q1 | $651K | Buy |
26,967
+1,566
| +6% | +$37.8K | ﹤0.01% | 1995 |
|
|
2022
Q4 | $750K | Sell |
25,401
-2,380
| -9% | -$70.3K | ﹤0.01% | 1932 |
|
|
2022
Q3 | $1.16M | Buy |
27,781
+929
| +3% | +$38.9K | ﹤0.01% | 1681 |
|
|
2022
Q2 | $755K | Sell |
26,852
-1,393
| -5% | -$39.2K | ﹤0.01% | 2036 |
|
|
2022
Q1 | $1.05M | Buy |
28,245
+5,344
| +23% | +$198K | ﹤0.01% | 1979 |
|
|
2021
Q4 | $1M | Buy |
22,901
+1,639
| +8% | +$71.6K | ﹤0.01% | 2039 |
|
|
2021
Q3 | $1.32M | Sell |
21,262
-647
| -3% | -$40.2K | ﹤0.01% | 1903 |
|
|
2021
Q2 | $1.87M | Sell |
21,909
-13,797
| -39% | -$1.18M | ﹤0.01% | 1762 |
|
|
2021
Q1 | $1.61M | Buy |
35,706
+22,209
| +165% | +$998K | ﹤0.01% | 1813 |
|
|
2020
Q4 | $92K | Buy |
+13,497
| New | +$92K | ﹤0.01% | 2631 |
|